470 related articles for article (PubMed ID: 30913899)
41. Caretakers' barriers to pediatric antiretroviral therapy adherence in Vietnam - A qualitative and quantitative study.
Tran CT; Pham TH; Tran KT; Nguyen TKC; Larsson M
Appl Nurs Res; 2017 Jun; 35():1-5. PubMed ID: 28532715
[TBL] [Abstract][Full Text] [Related]
42. Barriers and facilitators for transitioning of young people from adolescent clinics to adult ART clinics in Uganda: unintended consequences of successful adolescent ART clinics.
Mbalinda SN; Bakeera-Kitaka S; Lusota DA; Magongo EN; Musoke P; Kaye DK
BMC Health Serv Res; 2020 Sep; 20(1):835. PubMed ID: 32891150
[TBL] [Abstract][Full Text] [Related]
43. Differentiated Antiretroviral Therapy Delivery: Implementation Barriers and Enablers in South Africa.
Sharer M; Davis N; Makina N; Duffy M; Eagan S
J Assoc Nurses AIDS Care; 2019; 30(5):511-520. PubMed ID: 30720561
[TBL] [Abstract][Full Text] [Related]
44. 'Then her neighbour will not know her status': how health providers advocate antiretroviral therapy under universal test and treat.
Pell C; Reis R; Dlamini N; Moyer E; Vernooij E
Int Health; 2019 Jan; 11(1):36-41. PubMed ID: 30137387
[TBL] [Abstract][Full Text] [Related]
45. In what ways do communities support optimal antiretroviral treatment in Zimbabwe?
Scott K; Campbell C; Madanhire C; Skovdal M; Nyamukapa C; Gregson S
Health Promot Int; 2014 Dec; 29(4):645-54. PubMed ID: 23503291
[TBL] [Abstract][Full Text] [Related]
46. Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana.
Kebaabetswe P; Manyake K; Kadima E; Auletta-Young C; Chakalisa U; Sekoto T; Dintwa OM; Mmalane M; Makhema J; Lebelonyane R; Bachanas P; Plank R; Gaolathe T; Lockman S; Holme MP
AIDS Care; 2020 Jun; 32(6):722-728. PubMed ID: 31298037
[TBL] [Abstract][Full Text] [Related]
47. Perspectives on ART adherence among Zambian adults living with HIV: insights raised using HIV-related disability frameworks.
Hanass-Hancock J; Bond V; Solomon P; Cameron C; Maimbolwa M; Menon A; Nixon S
AIDS Care; 2020 May; 32(5):623-629. PubMed ID: 31416343
[TBL] [Abstract][Full Text] [Related]
48. Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada.
Logie CH; Lacombe-Duncan A; Wang Y; Kaida A; Conway T; Webster K; de Pokomandy A; Loutfy MR; Anema A; Becker D; Brotto L; Carter A; Cardinal C; Colley G; Ding E; Duddy J; Gataric N; Hogg RS; Hosward T; Jabbari S; Jones E; Kestler M; Langlois A; Lima V; Lloyd-Smith E; Medjuck M; Miller C; Money D; Nicholson V; Ogilvie G; Patterson S; Pick N; Roth E; Salters K; Sanchez M; Sas J; Sereda P; Summers M; Tom C; Wang L; Webster K; Zhang W; Abdul-Noor R; Angel J; Barry F; Bauer G; Beaver K; Benoit A; Bertozzi B; Borton S; Bourque T; Brophy J; Burchell A; Carlson A; Cioppa L; Cohen J; Conway T; Cooper C; Cotnam J; Cousineau J; Fraleigh A; Gagnier B; Gasingirwa C; Greene S; Hart T; Islam S; Kaushic C; Kennedy L; Kerr D; Kiboyogo M; Kwaramba G; Leonard L; Lewis J; Logie C; Margolese S; Muchenje M; Ndungʼu M; OʼBrien K; Ouellette C; Powis J; Quan C; Raboud J; Rachlis A; Ralph E; Rourke S; Rueda S; Sandre R; Smaill F; Smith S; Tigere T; Tharao W; Walmsley S; Wobeser W; Yee J; Yudin M; Baril JG; Burke NB; Clément P; Dayle J; Dubuc D; Fernet M; Groleau D; Hot A; Klein M; Martin C; Massie L; Ménard B; OʼBrien N; Otis J; Peltier D; Pierre A; Proulx-Boucher K; Rouleau D; Savoie É; Tremblay C; Trottier B; Trottier S; Tsoukas C; Gahagan J; Hankins C; Masching R; Ogunnaike-Cooke S
J Acquir Immune Defic Syndr; 2018 Feb; 77(2):144-153. PubMed ID: 29135650
[TBL] [Abstract][Full Text] [Related]
49. Community perspectives of South African adolescents' experiences seeking treatment at local HIV clinics and how such clinics may influence engagement in the HIV treatment cascade: a qualitative study.
Ritchwood TD; Ba A; Ingram L; Atujuna M; Marcus R; Ntlapo N; Oduro A; Bekker LG
AIDS Care; 2020 Jan; 32(1):83-88. PubMed ID: 31402674
[TBL] [Abstract][Full Text] [Related]
50. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
[TBL] [Abstract][Full Text] [Related]
51. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
Omonaiye O; Kusljic S; Nicholson P; Manias E
BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
[TBL] [Abstract][Full Text] [Related]
52. The Moderating Role of HIV Stigma on the Relationship between Perceived Social Support and Antiretroviral Therapy Adherence Self-Efficacy among Adult PLHIV in South Africa.
Luthuli MQ; John-Langba J
J Int Assoc Provid AIDS Care; 2024; 23():23259582241228743. PubMed ID: 38594925
[TBL] [Abstract][Full Text] [Related]
53. "I am adhering to HIV treatment so that I can live to support her": A qualitative study of upward intergenerational support in South Africa.
Schröder H; Mataboge P; McMahon SA; Gómez-Olivé FX; Schatz EJ; Bärnighausen T; De Neve JW
J Glob Health; 2024 May; 14():04083. PubMed ID: 38726557
[TBL] [Abstract][Full Text] [Related]
54. Barriers and facilitators to adherence for antiretroviral therapy: the perspectives of patients from a wellness center in the Mpumalanga Province, South Africa.
Simelane PT; Simelane MS; Amoateng AY
Afr Health Sci; 2022 Sep; 22(3):455-462. PubMed ID: 36910408
[TBL] [Abstract][Full Text] [Related]
55. A realist approach to eliciting the initial programme theory of the antiretroviral treatment adherence club intervention in the Western Cape Province, South Africa.
Mukumbang FC; Marchal B; Van Belle S; van Wyk B
BMC Med Res Methodol; 2018 May; 18(1):47. PubMed ID: 29801467
[TBL] [Abstract][Full Text] [Related]
56. Quality of life improvement, social stigma and antiretroviral treatment adherence: implications for long-term HIV/AIDS care.
Tran BX; Fleming M; Do HP; Nguyen LH; Latkin CA
AIDS Care; 2018 Dec; 30(12):1524-1531. PubMed ID: 30099885
[TBL] [Abstract][Full Text] [Related]
57. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
[TBL] [Abstract][Full Text] [Related]
58. Facilitators and Barriers to Adherence to Antiretroviral Therapy and Retention in Care Among Adolescents Living with HIV/AIDS in Zambia: A Mixed Methods Study.
Mesic A; Halim N; MacLeod W; Haker C; Mwansa M; Biemba G
AIDS Behav; 2019 Sep; 23(9):2618-2628. PubMed ID: 31093820
[TBL] [Abstract][Full Text] [Related]
59. Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model.
Eshun-Wilson I; Rohwer A; Hendricks L; Oliver S; Garner P
PLoS One; 2019; 14(1):e0210408. PubMed ID: 30629648
[TBL] [Abstract][Full Text] [Related]
60. "How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.
MacCarthy S; Saya U; Samba C; Birungi J; Okoboi S; Linnemayr S
BMC Public Health; 2018 Oct; 18(1):1158. PubMed ID: 30286746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
